BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30950846)

  • 1. Imaging the multiple sclerosis lesion: insights into pathogenesis, progression and repair.
    Wang CT; Barnett M; Barnett Y
    Curr Opin Neurol; 2019 Jun; 32(3):338-345. PubMed ID: 30950846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Dimensional Lesion Phenotyping and Physiologic Characterization Inform Remyelination Ability in Multiple Sclerosis.
    Sivakolundu DK; Hansen MR; West KL; Wang Y; Stanley T; Wilson A; McCreary M; Turner MP; Pinho MC; Newton BD; Guo X; Rypma B; Okuda DT
    J Neuroimaging; 2019 Sep; 29(5):605-614. PubMed ID: 31148298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
    Zhang Y; Jonkman L; Klauser A; Barkhof F; Yong VW; Metz LM; Geurts JJ
    Mult Scler; 2016 Oct; 22(12):1569-1577. PubMed ID: 26754802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlating new directional measures of myelin and axonal integrity in T2-weighted MRI with quantitative histology in multiple sclerosis.
    Sharma S; Laule C; Moore GRW; Li DKB; Zhang Y
    J Neurosci Methods; 2019 Jan; 311():369-376. PubMed ID: 30240805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis.
    Galbusera R; Bahn E; Weigel M; Schaedelin S; Franz J; Lu PJ; Barakovic M; Melie-Garcia L; Dechent P; Lutti A; Sati P; Reich DS; Nair G; Brück W; Kappos L; Stadelmann C; Granziera C
    Brain Pathol; 2023 Nov; 33(6):e13136. PubMed ID: 36480267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter Lesions.
    Zheng Y; Lee JC; Rudick R; Fisher E
    J Neuroimaging; 2018 Mar; 28(2):191-198. PubMed ID: 29076591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis.
    Giacomini PS; Arnold DL
    Curr Opin Neurol; 2008 Jun; 21(3):272-7. PubMed ID: 18451709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusivity in multiple sclerosis lesions: At the cutting edge?
    Klistorner A; Wang C; Fofanova V; Barnett MH; Yiannikas C; Parratt J; You Y; Graham SL
    Neuroimage Clin; 2016; 12():219-26. PubMed ID: 27489769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative magnetic resonance imaging reflects different levels of histologically determined myelin densities in multiple sclerosis, including remyelination in inactive multiple sclerosis lesions.
    Wiggermann V; Endmayr V; Hernández-Torres E; Höftberger R; Kasprian G; Hametner S; Rauscher A
    Brain Pathol; 2023 Nov; 33(6):e13150. PubMed ID: 36720269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions.
    Tagge IJ; Leppert IR; Fetco D; Campbell JS; Rudko DA; Brown RA; Stikov N; Pike GB; Giacomini PS; Arnold DL; Narayanan S
    Mult Scler; 2022 Nov; 28(13):2027-2037. PubMed ID: 35903888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
    Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal partial volume correction: Application to [
    Grecchi E; Veronese M; Bodini B; García-Lorenzo D; Battaglini M; Stankoff B; Turkheimer FE
    J Cereb Blood Flow Metab; 2017 Dec; 37(12):3803-3817. PubMed ID: 28569617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.
    Harrison DM; Li X; Liu H; Jones CK; Caffo B; Calabresi PA; van Zijl P
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1447-53. PubMed ID: 26939635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing myelin-sensitive magnetic resonance imaging measures and resulting g-ratios in healthy and multiple sclerosis brains.
    Berg RC; Menegaux A; Amthor T; Gilbert G; Mora M; Schlaeger S; Pongratz V; Lauerer M; Sorg C; Doneva M; Vavasour I; Mühlau M; Preibisch C
    Neuroimage; 2022 Dec; 264():119750. PubMed ID: 36379421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting PET-derived myelin content from multisequence MRI for individual longitudinal analysis in multiple sclerosis.
    Wei W; Poirion E; Bodini B; Tonietto M; Durrleman S; Colliot O; Stankoff B; Ayache N
    Neuroimage; 2020 Dec; 223():117308. PubMed ID: 32889117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-high field 7 T imaging in multiple sclerosis.
    Louapre C; Treaba CA; Barletta V; Mainero C
    Curr Opin Neurol; 2020 Aug; 33(4):422-429. PubMed ID: 32657883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial.
    Caverzasi E; Papinutto N; Cordano C; Kirkish G; Gundel TJ; Zhu A; Akula AV; Boscardin WJ; Neeb H; Henry RG; Chan JR; Green AJ
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2217635120. PubMed ID: 37155847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid PET in pseudotumoral multiple sclerosis.
    Matías-Guiu JA; Cabrera-Martín MN; Cortés-Martínez A; Pytel V; Moreno-Ramos T; Oreja-Guevara C; Carreras JL; Matías-Guiu J
    Mult Scler Relat Disord; 2017 Jul; 15():15-17. PubMed ID: 28641766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.